MBX Biosciences (MBX) Competitors $11.45 +0.09 (+0.79%) Closing price 06/10/2025 04:00 PM EasternExtended Trading$11.68 +0.23 (+2.01%) As of 04:26 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock MBX vs. TWST, IDYA, INDV, APGE, IRON, BHC, ARQT, BHVN, BEAM, and SDGRShould you be buying MBX Biosciences stock or one of its competitors? The main competitors of MBX Biosciences include Twist Bioscience (TWST), IDEAYA Biosciences (IDYA), Indivior (INDV), Apogee Therapeutics (APGE), Disc Medicine (IRON), Bausch Health Companies (BHC), Arcutis Biotherapeutics (ARQT), Biohaven (BHVN), Beam Therapeutics (BEAM), and Schrödinger (SDGR). These companies are all part of the "pharmaceutical products" industry. MBX Biosciences vs. Twist Bioscience IDEAYA Biosciences Indivior Apogee Therapeutics Disc Medicine Bausch Health Companies Arcutis Biotherapeutics Biohaven Beam Therapeutics Schrödinger Twist Bioscience (NASDAQ:TWST) and MBX Biosciences (NYSE:MBX) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, earnings, dividends, profitability, community ranking and risk. Which has higher valuation & earnings, TWST or MBX? MBX Biosciences has lower revenue, but higher earnings than Twist Bioscience. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTwist Bioscience$347.68M5.94-$208.73M-$3.25-10.60MBX BiosciencesN/AN/AN/AN/AN/A Does the MarketBeat Community favor TWST or MBX? Twist Bioscience received 101 more outperform votes than MBX Biosciences when rated by MarketBeat users. However, 100.00% of users gave MBX Biosciences an outperform vote while only 59.34% of users gave Twist Bioscience an outperform vote. CompanyUnderperformOutperformTwist BioscienceOutperform Votes10859.34% Underperform Votes7440.66% MBX BiosciencesOutperform Votes7100.00% Underperform VotesNo Votes Does the media favor TWST or MBX? In the previous week, Twist Bioscience had 3 more articles in the media than MBX Biosciences. MarketBeat recorded 5 mentions for Twist Bioscience and 2 mentions for MBX Biosciences. Twist Bioscience's average media sentiment score of 0.97 beat MBX Biosciences' score of 0.00 indicating that Twist Bioscience is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Twist Bioscience 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive MBX Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate TWST or MBX? Twist Bioscience presently has a consensus price target of $50.40, suggesting a potential upside of 46.30%. MBX Biosciences has a consensus price target of $37.50, suggesting a potential upside of 227.51%. Given MBX Biosciences' stronger consensus rating and higher possible upside, analysts plainly believe MBX Biosciences is more favorable than Twist Bioscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Twist Bioscience 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.70MBX Biosciences 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is TWST or MBX more profitable? MBX Biosciences has a net margin of 0.00% compared to Twist Bioscience's net margin of -59.76%. MBX Biosciences' return on equity of 0.00% beat Twist Bioscience's return on equity.Company Net Margins Return on Equity Return on Assets Twist Bioscience-59.76% -32.69% -25.25% MBX Biosciences N/A N/A N/A SummaryMBX Biosciences beats Twist Bioscience on 6 of the 11 factors compared between the two stocks. Get MBX Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MBX vs. The Competition Export to ExcelMetricMBX BiosciencesPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$382.71M$6.82B$5.57B$19.79BDividend YieldN/A2.49%5.27%3.84%P/E RatioN/A8.7927.2635.71Price / SalesN/A263.83424.2445.94Price / CashN/A65.8538.2517.52Price / BookN/A6.677.124.84Net IncomeN/A$143.49M$3.23B$1.02B7 Day Performance-16.06%5.15%3.79%2.29%1 Month Performance3.15%15.42%13.37%5.86%1 Year PerformanceN/A6.02%32.03%11.14% MBX Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MBXMBX Biosciences2.0415 of 5 stars$11.45+0.8%$37.50+227.5%N/A$382.71MN/A0.0036Positive NewsHigh Trading VolumeTWSTTwist Bioscience4.2368 of 5 stars$31.07+6.0%$50.40+62.2%-31.1%$1.76B$347.68M-9.19990IDYAIDEAYA Biosciences3.9079 of 5 stars$21.22+6.7%$54.27+155.8%-41.0%$1.74B$7M-6.4380Positive NewsAnalyst RevisionINDVIndivior1.9958 of 5 stars$12.46-3.1%$15.00+20.4%-19.3%$1.72B$1.17B-35.601,164Positive NewsAPGEApogee Therapeutics2.0681 of 5 stars$36.33-0.8%$94.60+160.4%-4.3%$1.67BN/A-15.0191IRONDisc Medicine2.0745 of 5 stars$47.73+2.2%$98.80+107.0%+33.6%$1.65BN/A-11.9930Positive NewsInsider TradeAnalyst RevisionBHCBausch Health Companies4.5755 of 5 stars$4.49-1.0%$7.42+65.4%-19.5%$1.64B$9.73B-37.3719,900Positive NewsARQTArcutis Biotherapeutics2.0572 of 5 stars$13.48+3.4%$18.80+39.5%+84.2%$1.61B$212.82M-7.53150Positive NewsBHVNBiohaven2.8055 of 5 stars$15.62+5.4%$59.46+280.8%-52.2%$1.59BN/A-1.67239Analyst RevisionHigh Trading VolumeBEAMBeam Therapeutics3.0762 of 5 stars$16.19+2.3%$48.75+201.1%-25.9%$1.59B$63.58M-9.20510SDGRSchrödinger2.4661 of 5 stars$21.69+0.3%$32.80+51.2%+22.4%$1.59B$230.49M-9.27790 Related Companies and Tools Related Companies Twist Bioscience Competitors IDEAYA Biosciences Competitors Indivior Competitors Apogee Therapeutics Competitors Disc Medicine Competitors Bausch Health Companies Competitors Arcutis Biotherapeutics Competitors Biohaven Competitors Beam Therapeutics Competitors Schrödinger Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:MBX) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MBX Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MBX Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MBX Stock Free MBX Stock Alerts